Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kawasaki disease.

J C Burns1

  • 1Department of Pediatrics, UCSD School of Medicine, La Jolla, Calif, USA.

Advances in Pediatrics
|August 2, 2001
PubMed
Summary
This summary is machine-generated.

Kawasaki disease is a critical childhood vasculitis leading to acquired heart disease. Early treatment with intravenous gamma globulin and aspirin prevents coronary artery damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kawasaki disease for the paediatric dermatologist: skin manifestations and new insights into the pathophysiology.

Clinical and experimental dermatology·2021
Same author

Characterization of circulating immune cells in acute Kawasaki disease suggests exposure to different antigens.

Clinical and experimental immunology·2020
Same author

Cardiovascular imaging in children and adults following Kawasaki disease.

Insights into imaging·2015
Same author

Pregnancy in women with a history of Kawasaki disease: management and outcomes.

BJOG : an international journal of obstetrics and gynaecology·2014
Same author

Methods for producing high titer, pantropic retroviral vectors for gene transfer into leukemic T-cells.

Methods in molecular medicine·2014
Same author

Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin.

Clinical and experimental immunology·2013
Same journal

Two Steps Forward-One Step Back: Keeping Pace with Advances.

Advances in pediatrics·2025
Same journal

Pediatric Lymphadenopathy.

Advances in pediatrics·2025
Same journal

Vascular and Gastrointestinal Access in Children.

Advances in pediatrics·2025
Same journal

The Ouchless Pediatric Emergency Department.

Advances in pediatrics·2025
Same journal

Seizures and Shaking in Newborns and Babies.

Advances in pediatrics·2025
Same journal

Procalcitonin in Pediatric Emergency Medicine.

Advances in pediatrics·2025
See all related articles

Area of Science:

  • Pediatrics
  • Cardiology
  • Rheumatology

Background:

  • Kawasaki disease is a leading cause of acquired heart disease in children.
  • Its etiology is suspected to be infectious but remains unknown.
  • It affects infants and young children, presenting with fever and inflammation.

Purpose of the Study:

  • To summarize the key aspects of Kawasaki disease.
  • To highlight the importance of timely diagnosis and treatment.
  • To inform pediatric care providers on distinguishing it from other febrile illnesses.

Main Methods:

  • Review of clinical presentation and diagnostic indicators.
  • Discussion of treatment protocols and their efficacy.
  • Emphasis on the critical treatment window.

Related Experiment Videos

Main Results:

  • Untreated Kawasaki disease leads to coronary artery damage in 25% of cases.
  • Intravenous gamma globulin and aspirin are effective treatments.
  • Prompt administration within 10 days is crucial for preventing complications.

Conclusions:

  • Kawasaki disease requires rapid diagnosis to prevent long-term cardiac sequelae.
  • Effective treatment is available if initiated early.
  • Distinguishing it from other pediatric fever syndromes is vital for prompt management.